Our central hypothesis is that host HLA Class I molecules regulate the phenotype and function of NK subsets and the repertoire of NK receptors. We propose to test the following hypotheses: (1) host HLA class I phenotype influences the repertoire of NK subsets, (2) host HLA class I phenotype affects NK receptor cell surface density and (3) NK cell repertoire in primary cells differs from NK clones. These hypotheses will be tested by three innovative methods: (a) four-color FACS for complex receptor expression on NK cells, (2) single cell RT-PCR to determine the repertoire of NK receptors in individual NK cells and (3) the surface expression of NK receptors on NK subsets by a quantitative FACS assay. Finally we will compare the NK repertoire of primary peripheral blood cells with that of NK clones generated from cells of donors who are homozygous or heterozygous for HLA-B or C/MICA specificities. We will also test NK clones for cytotoxic activity against a panel of self HLA class I-transfected target cells to determine whether there is an association between NK receptor phenotype and NK function. The data of the proposed studies should provide conclusive evidence for the HLA-dependent changes in the sizes of specific NK cell subsets, the repertoire of specific NK receptors and NK clone function. Understanding the genetic factors that influence the development of NK subsets and the receptors that define their repertoire will be important in the assignment of risks for rejection or for graft-versus-host reaction following bone marrow transplantation or NK-mediated killing of virus-infected cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL029583-16A1
Application #
6412998
Study Section
Project Start
2000-12-01
Project End
2001-11-30
Budget Start
Budget End
Support Year
16
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Immune Disease Institute, Inc.
Department
Type
DUNS #
115524410
City
Boston
State
MA
Country
United States
Zip Code
02115
Feris, Edmond J; Encinales, Liliana; Awad, Carlos et al. (2016) High levels of anti-tuberculin (IgG) antibodies correlate with the blocking of T-cell proliferation in individuals with high exposure to Mycobacterium tuberculosis. Int J Infect Dis 43:21-24
Larsen, Charles E; Alford, Dennis R; Trautwein, Michael R et al. (2014) Dominant sequences of human major histocompatibility complex conserved extended haplotypes from HLA-DQA2 to DAXX. PLoS Genet 10:e1004637
Granados-Montiel, Julio; Zuniga, Joaquin; Azocar, Jose et al. (2011) Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection. Immunobiology 216:686-91
Encinales, Liliana; Zuniga, Joaquin; Granados-Montiel, Julio et al. (2010) Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mol Immunol 47:1066-73
Szilagyi, Agnes; Banlaki, Zsofia; Pozsonyi, Eva et al. (2010) Frequent occurrence of conserved extended haplotypes (CEHs) in two Caucasian populations. Mol Immunol 47:1899-904
Zúñiga, Joaquín; Romero, Viviana; Azocar, José et al. (2009) Protective KIR-HLA interactions for HCV infection in intravenous drug users. Mol Immunol 46:2723-7
Stern, Joel N H; Keskin, Derin B; Romero, Viviana et al. (2009) Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol Res 45:1-12
Husain, Zaheed; Kelly, M Ann; Eisenbarth, George S et al. (2008) The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1. J Autoimmun 30:266-72
Romero, Viviana; Zuniga, Joaquin; Azocar, Jose et al. (2008) Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes. Mol Immunol 45:3857-62
Romero, Viviana; Azocar, Jose; Zuniga, Joaquin et al. (2008) Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol 45:2429-36

Showing the most recent 10 out of 137 publications